Publicaciones en colaboración con investigadores/as de Chinese University of Hong Kong (1)

2017

  1. Results from the Phase III Randomized Trial of Onartuzumab plus Erlotinib Versus Erlotinib in Previously Treated Stage IIIB or IV Non–Small-Cell Lung Cancer: METLung

    Journal of Clinical Oncology, Vol. 35, Núm. 4